SBRA · Sabra Health Care REIT, Inc.
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $859.56M | $774.63M | $703.24M | $647.51M | $624.81M | $569.55M | $598.57M | $661.74M | $623.41M | $408.28M | $260.53M | $238.86M | $183.52M | $134.78M | $103.17M | $84.23M | |
| $374.63M | $374.13M | $381.5M | $376.27M | $400.59M | $396.72M | $430.58M | $452.14M | $536.61M | $364.19M | $225.28M | $209.85M | $161.48M | $128.99M | $101.74M | $80.68M | |
| $60.15M | $53.71M | $50.07M | $47.47M | $39.57M | $34.67M | $32.76M | $30.89M | $37.09M | $32.4M | $17.67M | $16.09M | $23.82M | $16.42M | $16.1M | $14.47M | |
| — | $19.09M | $7.5M | $11.62M | $17.59M | $8.69M | $10.62M | $17.67M | — | — | — | — | — | — | — | — | |
| $209.43M | $187M | $169.62M | $183.09M | $187.78M | $178.99M | $176.74M | $181.55M | $191.38M | $113.88M | $68.47M | $63.08M | $43.33M | $33.28M | $30.26M | $26.59M | |
| $3.66M | $7.32M | $18.47M | $14.33M | $94.04M | $9.5M | $4M | $121.82M | $1.41M | $1.33M | $29.81M | $0 | $0 | $0 | $2.48M | $0 | |
| — | — | — | — | — | — | — | — | — | — | — | $2.58M | $1.93M | — | — | — | |
| — | $9.36M | $4.83M | -$75.57M | -$13.52M | -$21.95M | $4.48M | -$11.95M | $129.76M | $52.01M | $4M | $2.1M | — | — | — | — | |
| $7.01M | $3.93M | -$397K | -$2.9M | -$40.25M | -$27.96M | -$16.6M | -$6.8M | -$5.43M | $0 | $0 | — | — | — | — | — | |
| $60.35M | $153.42M | $128.11M | $18.66M | $21.67M | $80.67M | $155.73M | $79.22M | $287.56M | $159.02M | $71.25M | $80.13M | — | — | $19.51M | $12.84M | |
| $2.13M | $1.84M | $1.01M | $2M | $1.24M | $1.85M | $710K | $3.4M | $3.01M | $651K | $1.05M | $749K | $0 | $0 | $0 | $0 | |
| $65.44M | $155.61M | $126.71M | $13.76M | -$77.61M | -$113.26M | $138.42M | $69M | $279.08M | $158.38M | $70.28M | $79.41M | $46.95M | $33.72M | $19.51M | $12.84M | |
| — | 20.09% | 18.02% | 2.12% | -12.42% | -19.89% | 23.12% | 10.43% | 44.77% | 38.79% | 26.97% | 33.25% | 25.58% | 25.01% | 18.91% | 15.25% | |
| -$212K | -$99K | $0 | $0 | — | $0 | $0 | $22K | $33K | -$18K | -$71K | -$30K | -$43K | $0 | $0 | — | |
| -$51.79M | — | — | — | — | — | $138.42M | $69M | $269.31M | $148.14M | $60.03M | $69.17M | $36.71M | $25.75M | $19.51M | $12.84M | |
| $73.57M | $131.1M | $123.91M | $18.44M | -$48.52M | -$83.37M | $110.89M | $44.31M | $280.09M | $171.47M | $75.81M | $73.62M | $45.41M | $33.72M | $19.51M | — | |
| USD/shares | $0.25 | $0.64 | $0.54 | $0.06 | -$0.34 | -$0.52 | $0.67 | $0.37 | $1.51 | $1.40 | $0.92 | $1.11 | $0.79 | $0.69 | $0.53 | $0.43 |
| USD/shares | $0.26 | $0.64 | $0.54 | $0.06 | -$0.34 | -$0.52 | $0.67 | $0.37 | $1.51 | $1.40 | $0.92 | $1.11 | $0.78 | $0.68 | $0.52 | $0.43 |
| shares | — | 241.31M | 233.5M | 231.2M | 230.95M | 219.07M | 206.22M | 187.17M | 178.31M | 105.62M | 65.28M | 62.24M | 46.35M | 37.51M | 37.06M | 30.11M |
| shares | — | 244.5M | 236.05M | 232.79M | 230.95M | 219.07M | 207.25M | 188.13M | 178.72M | 105.84M | 65.52M | 62.46M | 46.89M | 38.07M | 37.32M | 30.17M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2011–FY2025: $2.96B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 12 similar-size REIT - Healthcare Facilities companies (of 17 listed).
P/FFO and P/AFFO and EV/Adj. EBITDA use the company-stated “FFO attributable to Sabra Health Care REIT, Inc.” and “AFFO attributable to Sabra Health Care REIT, Inc.” and “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.
Valuation over time computed as of each quarter's filing date
P/FFO and P/AFFO and EV/Adj. EBITDA use the company-stated “FFO attributable to Sabra Health Care REIT, Inc.” and “AFFO attributable to Sabra Health Care REIT, Inc.” and “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Health Care Resident Service Ancillary Service | $4,900,000 | $3,900,000 | $2,000,000 | $1,500,000 | $1,300,000 | $900,000 | $800,000 | — |
| Ancillary Services | — | — | — | — | — | $900,000 | $800,000 | $500,000 |